Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder |
Has concentration strength denominator unit |
True |
g |
Inferred relationship |
Some |
3 |
Product containing precisely meropenem 1 gram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Product containing precisely alprostadil 3 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has concentration strength denominator unit |
True |
g |
Inferred relationship |
Some |
1 |
Product containing precisely fosfomycin (as fosfomycin sodium) 4 gram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Fosfomycin (as fosfomycin sodium) 4 g powder for solution for infusion and/or injection vial |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Fosfomycin (as fosfomycin sodium) 2 g powder for solution for infusion vial |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Product containing precisely fosfomycin (as fosfomycin sodium) 2 gram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Product containing precisely paracetamol 1 gram/1 sachet powder for conventional release oral solution (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Product containing precisely ivermectin 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has concentration strength denominator unit |
True |
g |
Inferred relationship |
Some |
1 |
Product containing precisely hydroxocobalamin 2.5 gram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Glucosamine sulfate (as glucosamine sulfate sodium chloride) 1.5 g powder for oral solution sachet |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Product containing precisely zinc undecylenate 100 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has concentration strength denominator unit |
True |
g |
Inferred relationship |
Some |
1 |
Human fibrinogen 1 g powder for solution for infusion and/or injection vial |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Product containing precisely permethrin 10 milligram/1 gram conventional release cutaneous solution (clinical drug) |
Has concentration strength denominator unit |
True |
g |
Inferred relationship |
Some |
1 |
Product containing precisely vancomycin (as vancomycin hydrochloride) 1 gram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Product containing precisely vancomycin (as vancomycin hydrochloride) 1 gram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Product containing precisely malathion 500 microgram/1 gram conventional release cutaneous emulsion (clinical drug) |
Has concentration strength denominator unit |
True |
g |
Inferred relationship |
Some |
1 |
Product containing precisely zinc undecylenate 100 milligram/1 gram conventional release cutaneous powder (clinical drug) |
Has concentration strength denominator unit |
True |
g |
Inferred relationship |
Some |
1 |
Diclofenac sodium 40 mg/g cutaneous spray |
Has concentration strength denominator unit |
True |
g |
Inferred relationship |
Some |
1 |
Clindamycin (as clindamycin phosphate) 20 mg/g vaginal cream |
Has concentration strength denominator unit |
True |
g |
Inferred relationship |
Some |
1 |
Aztreonam 1 g powder for solution for infusion and/or injection vial |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Product containing precisely aztreonam 2 gram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Product containing precisely erythromycin (as erythromycin lactobionate) 1 gram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Product containing precisely erythromycin (as erythromycin lactobionate) 1 gram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Calcium carbonate 1.25 g effervescent oral tablet |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Product containing precisely calcium carbonate 1.25 gram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Calcium acetate 1 g oral tablet |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Calcium carbonate 1.25 g and cholecalciferol 5 microgram oral tablet |
Has presentation strength numerator unit |
False |
g |
Inferred relationship |
Some |
1 |
Methenamine hippurate 1 g oral tablet |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Product containing precisely methenamine mandelate 1 gram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Nalidixic acid 1 g oral tablet |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Hydroxyurea 1 g oral tablet |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Cefadroxil 1 g oral tablet |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Metformin hydrochloride 1 g oral tablet |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Product containing precisely methenamine hippurate 1 gram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Product containing precisely sucralfate 1 gram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Piracetam 1.2 g oral tablet |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Levetiracetam 1 g oral tablet |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Product containing precisely sulfalene 2 gram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Product containing precisely monobasic sodium phosphate 1.5 gram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Valacyclovir hydrochloride 1 g oral tablet |
Has presentation strength numerator unit |
False |
g |
Inferred relationship |
Some |
1 |
Fish derived omega 3 fatty acid 1 g oral capsule |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Product containing precisely colestipol hydrochloride 1 gram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Glycerin 2 g rectal suppository |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Product containing precisely glycerol 4 gram/1 each conventional release rectal suppository (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Product containing precisely glycerol 1 gram/1 each conventional release rectal suppository (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Product containing precisely calcium carbonate 1.5 gram/1 each conventional release chewable tablet (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Product containing precisely calcium carbonate 2.5 gram/1 each conventional release chewable tablet (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Calcium carbonate 1.25 g chewable tablet |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Product containing precisely calcium gluconate 1 gram/1 each conventional release effervescent oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Niacin 1 g prolonged-release oral tablet |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Metformin hydrochloride 1 g prolonged-release oral tablet |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Product containing precisely procainamide hydrochloride 1 gram/1 each prolonged-release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
céfazoline 1 g, fiole de poudre pour solution injectable (médicament clinique) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Product containing precisely activated charcoal 5 gram/1 sachet conventional release oral granules (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
céfradine 1 g, pour injection (poudre pour reconstitution) (médicament clinique) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength numerator unit |
False |
g |
Inferred relationship |
Some |
1 |
céfotaxime 1 g, pour injection (poudre pour reconstitution) (médicament clinique) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
ceftazidime 3 g, flacon de poudre pour solution injectable (médicament clinique) |
Has presentation strength numerator unit |
False |
g |
Inferred relationship |
Some |
1 |
céfoxitine 1 g, fiole de poudre pour solution injectable (médicament clinique) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
aztréonam 1 g, fiole de poudre pour solution injectable (médicament clinique) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
céfoxitine 2 g, pour injection (poudre pour reconstitution) (médicament clinique) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
aztréonam 2 g, fiole de poudre pour solution injectable (médicament clinique) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Product containing precisely benorilate 2 gram/1 sachet granules for conventional release oral suspension (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
ceftazidime 1 g, pour injection (poudre pour reconstitution) (médicament clinique) |
Has presentation strength numerator unit |
False |
g |
Inferred relationship |
Some |
1 |
Cyclophosphamide (as cyclophosphamide monohydrate) 1 g powder for solution for injection vial |
Has presentation strength numerator unit |
False |
g |
Inferred relationship |
Some |
1 |
chloramphénicol 1 g, fiole de poudre pour injection (médicament clinique) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Deferoxamine mesylate 2 g powder for solution for injection vial |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
pénicilline G 1 200 mg, pour injection (poudre pour reconstitution) (médicament clinique) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
ceftazidime 2 g, pour injection (poudre pour reconstitution) (médicament clinique) |
Has presentation strength numerator unit |
False |
g |
Inferred relationship |
Some |
1 |
Product containing precisely calcium carbonate 2.5 gram/1 sachet granules for conventional release oral suspension (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
ceftriaxone 1 g, pour injection (poudre pour reconstitution) (médicament clinique) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
ceftriaxone 2 g, pour injection (poudre pour reconstitution) (médicament clinique) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
capréomycine 1 g, fiole de poudre pour solution injectable (médicament clinique) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
cefpirome 1 g, fiole de poudre pour solution injectable (médicament clinique) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
cefpirome 2 g, fiole de poudre pour solution injectable (médicament clinique) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
amoxicilline 1 g, pour injection (poudre pour reconstitution) (médicament clinique) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Ifosfamide 1 g powder for solution for injection vial |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Ifosfamide 2 g powder for solution for injection vial |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Treosulfan 5 g powder for solution for injection vial |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
méropenem 1 g, fiole de poudre pour solution injectable (médicament clinique) |
Has presentation strength numerator unit |
False |
g |
Inferred relationship |
Some |
1 |
floxacilline 1 g, fiole de poudre pour solution injectable (médicament clinique) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
érythromycine 1g, fiole de poudre pour perfusion (médicament clinique) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Streptomycin (as streptomycin sulfate) 1 g powder for solution for injection vial |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
vancomycine 1 g, fiole de poudre pour perfusion (médicament clinique) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Treosulfan 1 g powder for solution for injection vial |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Product containing precisely gemcitabine (as gemcitabine hydrochloride) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Mesalamine 1 g gastro-resistant and prolonged-release oral granules sachet |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Product containing precisely codeine phosphate 60 milligram and paracetamol 1 gram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
2 |
Product containing precisely ispaghula husk 3.5 gram and mebeverine hydrochloride 135 milligram/1 sachet granules for conventional release oral suspension (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Guar gum 5 g granules for oral suspension sachet |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Sodium citrate 4 g granules for oral solution sachet |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Product containing precisely potassium aminobenzoate 3 gram/1 sachet powder for conventional release oral solution (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Product containing precisely ispaghula husk 3.5 gram/1 sachet granules for conventional release oral suspension (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Product containing precisely durapatite 3.32 gram/1 sachet conventional release oral granules (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Ispaghula husk 6 g powder for oral suspension sachet |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Galactose 3.99 g and palmitic acid 4 mg powder for suspension for injection vial |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
Product containing precisely calcium phosphate 3.3 gram/1 sachet powder for conventional release oral suspension (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
pipéracilline 2 g/tazobactam 250 mg, fiole de poudre pour solution injectable (médicament clinique) |
Has presentation strength numerator unit |
False |
g |
Inferred relationship |
Some |
2 |
pipéracilline 4 g/tazobactam 500 mg, fiole de poudre pour solution injectable (médicament clinique) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
amoxicilline et clavulanate de potassium 1 mg/200 mg, fiole de poudre pour solution injectable (médicament clinique) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |